MOUNT BETHEL, Pa. & STARNBERG, Germany--Aenova Group announced today that it has signed a definitive agreement to sell Swiss Caps USA’s softgel manufacturing facility in Miami, FL, to Marine Ingredients, a leading omega-3 manufacturer. As part of the agreement, the employees currently working in Miami will transfer from Swiss Caps USA to Innova Softgel, LLC, a newly formed subsidiary of Marine Ingredients. Both parties agreed not to disclose financial details of the transaction, which is expected to be closed by the end of December.
"The Swiss Caps acquisition is very attractive to us for a number of reasons. First and foremost, is the talented Swiss Caps team of seasoned professionals who take pride in producing high quality products for a broad spectrum of U.S. and international customers — servicing these customers will remain their focus. Additionally, Marine Ingredients will gain the last piece in our quest to be fully vertically-integrated, improving the traceability and transparency of the entire supply chain for customers. Finally, because of Swiss Caps' various certifications and licenses, including OTC, TGA, NSF, Halal and MSC, we will be better able to serve the market as global business opportunities are pursued,” said Olav Sandnes, President of Marine Ingredients.
“We are extremely pleased to find a strong organization such as Marine Ingredients to carry on the future success of the Miami site,” stated Marcus Boening, CFO, Aenova Group.
About Marine Ingredients
Marine Ingredients has been in the omega-3 business since 1984, and is a leading producer of quality omega-3 softgel and liquid formulations for brands serving health food stores, practitioners, direct response, the non-prescription medical market, direct selling, and the mass market. Marine Ingredients partners with quality-conscious brands to develop and craft unique products with meaningful points-of-difference. Marine ingredients is a fully vertically integrated company, offering our customers a comprehensive range of omega-3 products, backed by scientific and technical support, and deep market knowledge that spans more than 30 years. Further information on Marine Ingredients is available at www.marine-ingredients.com.
About Aenova Group
With a planned turnover of around EUR 750 million in the current financial year, the Aenova Group is one of the leading companies in the global pharmaceutical and healthcare industry.
The group’s portfolio of services covers the entire value chain for the development and production of all the main dosage forms and product groups in the field of medicines and dietary supplements. The Aenova Group’s high standards of quality, innovative technologies and clear vision for the future have enabled it to become European market leader in the business-to-business field. The company, which has its headquarters near Munich, operates 29 sites in eleven countries throughout the world. More than 4700 employees contribute to the group’s success.